5062: Began Phase I testing

Active Biotech AB (SSE:ACTI B), Lund, Sweden Product: 5062 Business: Autoimmune/Inflammation Therapeutic category: Immune modulation Target: Immune cells Description: Oral immune modulating SAIK comp...